Abrogation of the G2 Checkpoint by Inhibition of Wee-1 Kinase Results in Sensitization of p53-Deficient Tumor Cells to DNA-Damaging Agents

Publisher： Bentham Science Publishers

E-ISSN： 2212-3938|5|3|186-191

ISSN： 1574-8847

Source： Current Clinical Pharmacology, Vol.5, Iss.3, 2010-08, pp. : 186-191

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Analogs of Staurosporine - a potent abrogator of G2 checkpoint function in cancer cells with disrupted P53

By Gescher A.  

General Pharmacology, Vol. 31, Iss. 5, 1998-11 ,pp. : 721-728

Elsevier

Access to resources Recommend Favorite

The DNA-damaging potential of tamoxifen in breast cancer and normal cells

By Wozniak Katarzyna   Kolacinska Agnieszka   Blasinska-Morawiec Maria   Morawiec-Bajda Alina   Morawiec Zbigniew   Zadrozny Marek   Blasiak Janusz  

Archives of Toxicology, Vol. 81, Iss. 7, 2007-07 ,pp. : 519-527

Springer Publishing Company

Access to resources Recommend Favorite

Interaction of Tumor Suppressor p53 with DNA and Proteins

By  

Current Pharmaceutical Biotechnology, Vol. 11, Iss. 1, 2010-01 ,pp. : 122-127

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticle-mediated p53 gene therapy for tumor inhibition

By Sharma Blanka  

Drug Delivery and Translational Research, Vol. 1, Iss. 1, 2011-02 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Current Inhibitors of Checkpoint Kinase 2

By  

Current Medicinal Chemistry, Vol. 18, Iss. 28, 2011-10 ,pp. : 4368-4374

Bentham Science Publishers

Access to resources Recommend Favorite